Analyst Recommendations And Earnings Forecast: Anthera Pharmaceuticals, Inc. (ANTH), Civeo Corporation (CVEO)

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) last session’s volume of 0.46 million shares was higher than its average volume of 0.41 million shares. The stock, after opening at $1.56, hit $1.71 through the close by scoring 8.92%.

Anthera Pharmaceuticals, Inc. (ANTH) Analyst Opinion

Anthera Pharmaceuticals, Inc. has a consensus hold rating from 5 Wall Street analysts, and the number of shares currently sold short amount to at least 14.08% of shares outstanding. The stock spiked 17.93% last month and is down -67.07 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover ANTH having a buy-equivalent rating. Analysts have placed a $6.75 price target on Anthera Pharmaceuticals, Inc., suggesting a 294.74% gain from recent close. It’s currently trading about -92.39% below its 52-week high.

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Intraday View

This stock (ANTH) is ahead of its 52-week low with 42.5%. Its last month’s stock price volatility remained 11.05% which for the week stands at 10.14%. The share price has moved forward from its 20 days moving average, trading at a distance of 4.46% and stays 15.4% away from its 50 days moving average. Over the last five days, shares have managed 5.56% gains and now is down -34.27% since hitting its 200-day moving average of $1.48. Anthera Pharmaceuticals, Inc. (ANTH) has made its way to a 12-month decline of -91.24%.

Turning to Civeo Corporation (NYSE:CVEO), its shares were trading at $2 a retreat of $-0.27, on the trading floor. The stock, after opening at $2.26, touched a high of $2.28 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.3. Civeo Corporation has 1 buy ratings, 1 holds and 0 sells even after the stock tumbled -46.38% from its high of $ 3.73 to a $261.28 million market value through last close.

Civeo Corporation (CVEO) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 2 to 2 during a month. Analysts set a 12-month price target of $4 a share. The target implies a 100% spike from where the shares are currently trading. Also, the current price highlights a discount of 150% to analysts’ high consensus price target.

Civeo Corporation (NYSE:CVEO) Intraday Trading

The counter witnessed a trading volume of 1.96 million shares versus an average volume of 0.7 million shares during last trading session. Its last month’s stock price volatility remained 8.27% which for the week approaches 5.91%. The lowest price the stock reached in the last trading day was $1.86 and compares with the $1.08 52-week low. The stock recovered 85.19% since its low point and has performed -9.09% year-to-date.

SHARE